Prakash Nallathamby

Professor Nallathamby's interdisciplinary research is federally funded and at the interface of chemistry, materials science, chemical engineering, and biological systems on the micro/nanoscale. Current interests include structure-controlled nanotherapeutics to tackle MDR bacterial infections, label-free targeting of cancer cells, label-free cell-specific gene editing, and off-the-shelf CAR-T cells for cancer immunotherapy. He has over 15 years of experience in the synthesis of nanoparticles for biomedical applications with significant expertise in tuning surface properties of nanomaterials. The nanomaterials synthesized are single elements, anisotropic nanoparticles, core-shell nanostructures, or soft polymers. His surface-modified nanomaterials were used for real-time in-situ bio-sensing of receptor distribution on live cancer cells, as diagnostic agents to detect mechanisms of drug resistance in cancer cells, and as multi-modal nanoprobes in vivo. He is also highly adept at mitigatin